Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>Mario Tumbarello, Pierluigi Viale, Enrico Maria Trecarichi et al.|Clinical Infectious Diseases|2018Cited by 351
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter StudyMario Tumbarello, Pierluigi Viale, Alberto Corona et al.|Clinical Infectious Diseases|2021Cited by 264
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAMMatteo Bassetti, Esther Segal, Daniele Roberto Giacobbe et al.|Intensive Care Medicine|2024Cited by 171
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort studyMartin Hoenigl, Emmanuel Roilides, Jon Salmanton‐García et al.|The Lancet Infectious Diseases|2023Cited by 137
Tocilizumab and steroid treatment in patients with COVID-19 pneumoniaMałgorzata Mikulska, Matteo Bassetti, Laura Ambra Nicolini et al.|PLoS ONE|2020Cited by 128